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Accepted 6 January 2012AbstractFetal akinesia deformation sequence is a clinically and genetically heterogeneous disorder characterized by a variable combination of
arthrogryposis, fetal akinesia, intrauterine growth restriction, developmental abnormalities such as cystic hygroma, pulmonary hypoplasia, cleft
palate, cryptorchidism, cardiac defects and intestinal malrotation, and occasional pterygia of the limbs. Multiple pterygium syndrome is
a clinically and genetically heterogeneous disorder characterized by pterygia of the neck, elbows and/or knees, arthrogryposis, and other
phenotypic features such as short stature, genital abnormalities, craniofacial abnormalities, clubfoot, kyphoscoliosis, and cardiac abnormalities.
Fetal akinesia deformation sequence may phenotypically overlap with the lethal type of multiple pterygium syndrome. This article provides
a comprehensive review of prenatal diagnosis and genetic analysis of fetal akinesia deformation sequence and multiple pterygium syndrome
associated with neuromuscular junction disorders. Prenatal diagnosis of fetal akinesia along with cystic hygroma, increased nuchal translucency,
nuchal edema, hydrops fetalis, arthrogryposis, pterygia, and other structural abnormalities should include a differential diagnosis of neuro-
muscular junction disorders. Genetic analysis of mutations in the neuromuscular junction genes such as CHRNA1, CHRND, CHRNG, CNTN1,
DOK7, RAPSN, and SYNE1 may unveil the pathogenetic cause of fetal akinesia deformation sequence and multiple pterygium syndrome, and the
information acquired is helpful for genetic counseling and clinical management.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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doi:10.1016/j.tjog.2012.01.004fetal akinesia, intrauterine growth restriction (IUGR), devel-
opmental abnormalities such as cystic hygroma, pulmonary
hypoplasia, cleft palate, cryptorchidism, cardiac defects and
intestinal malrotation, and occasional pterygia of the limbs
[1e5]. In a retrospective population-based study in Demark,
Bayat et al [6] reported that the incidence of FADS was
1:15,000. FADS was originally reported by Pena and Shokeir
[1] and Lindhout et al [3] to describe a disorder called
PenaeShokeir syndrome consisting of the symptoms of IUGR,
polyhydramnios, facial dysmorphism, pulmonary hypoplasia,cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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or high-arched palate and bell-shaped chest. The pathogenetic
mechanisms of FADS include neuropathy, muscular disorders,
neuromuscular junction (NMJ) disorders, maternal myasthenia
gravis, restrictive dermopathy, and others [5,7e12]. FADS
may phenotypically overlap with the lethal type of multiple
pterygium syndrome (LMPS; OMIM 253290). Multiple
pterygium syndrome (MPS) is a clinically and genetically
heterogeneous disorder characterized by pterygia (webbing) of
the neck, elbows and/or knees, arthrogryposis (joint contrac-
tures), and other phenotypic features such as short stature,
genital abnormalities, craniofacial abnormalities, clubfoot,
kyphoscoliosis, and cardiac abnormalities [13e15]. MPS
can occur in autosomal-recessive [12,16e18], autosomal-
dominant [19], or X-linked-dominant [20] transmission.
Genetic analysis of mutations in the genes associated with
NMJ in fetuses with FADS/MPS
FADS and/or MPS have been reported to be caused by
mutations in the genes associated with NMJ such as CHRNA1
(OMIM 100690), CHRND (OMIM 100720), CHRNG (OMIM
100730), RAPSN (OMIM 601592), DOK7 (OMIM 610285),
CNTN1 (OMIM 600016), and SYNE1 (OMIM 608441).CHRNA1CHRNA1, CHRNB1 (OMIM 100710), CHRND, CHRNG,
andCHRNE (OMIM 100725) encode the acetylcholine receptor
(AchR) subunits ofa1, b1, d,g, and ε, respectively. TheAchR of
fetal type consists ofa1 (two) subunits and one of eachb1, d, and
g subunits, whereas the AchR of adult type consists of two a1,
b1, d, and ε subunits because of replacement of the fetal g
subunit by the adult ε subunit after 33 weeks of gestation
[21e23]. Heterozygous mutations of CHRNA1 can cause
autosomal dominant congenital slow-channel myasthenic
syndrome (OMIM 601462) and congenital fast-channel myas-
thenic syndrome (OMIM 608930). Homozygous mutations of
CHRNA1 have been reported to cause autosomal-recessive
LMPS [12]. Michalk et al [12] reported two male sib fetuses
in a consanguineous Pakistani family with LMPS and a homo-
zygous mutation of c.761 G/T in CHRNA1 that predicts
R234L inmature protein andR245L in precursor. The first fetus
was stillborn at 24weeks of gestationwith IUGR, edema, cystic
hygroma, decreased movements, joint contractures, faciocra-
nial dysmorphism, cleft palate, micrognathia, reduced muscle
bulk, scoliosis, contractures, and pterygia. The second fetus
was terminated at 20 weeks of gestation with similar pheno-
typic features as the first fetus and an additional finding of
rocker-bottom feet. Michalk et al [12] reported another two
male sib fetuses in a non-consanguineous African family with
LMPS and a homozygous mutation of c.117_133dup17 in
CHRNA1 that predicts H25RfsX19 in mature protein or
H45RfsX19 in precursor. The first fetus was stillborn at 28
weeks of gestation. The second fetus was terminated at
17 weeks of gestation with IUGR, edema, cystic hygroma at
7 weeks of gestation, decreased movements, joint contractures,faciocranial dysmorphism, down-slanting palpebral fissures,
a depressed nasal bridge, micrognathia, low-set ears, contrac-
tures, and pterygia.CHRNDHeterozygous mutations of CHRND can cause autosomal-
dominant congenital slow-channel myasthenic syndrome and
congenital fast-channel myasthenic syndrome. Homozygous
or compound heterozygous mutations in CHRND have been
reported to cause autosomal recessive LMPS [12]. Michalk
et al [12] reported two male sib fetuses in a consanguineous
Turkish family with LMPS and a homozygous mutation of
c.234 G/A in CHRND that predicts W57X in mature protein
or W78X in precursor. Both fetuses were terminated at 15
weeks of gestation and manifested IUGR, edema, cystic
hygroma, decreased movements, and joint contractures. One
fetus additionally showed cystic hygroma, muscle hypoplasia,
scoliosis, contractures, pectus excavatum, broad ribs and
clavicles, and pterygia. Michalk et al [12] also reported five
sib fetuses in a non-consanguineous German family with
LMPS and compound heterozygous mutations of c.283 T/C/
c.1390C/T in CHRND that predict F74L/R443X in mature
protein or F95L/R464X in precursor. The first female fetus
was delivered at 23 gestational weeks with neonatal death,
generalized edema, a depressed nasal bridge, low-set ears,
a big atrial septal defect, lung hypoplasia, hydrothorax, and
ascites. The second female fetus was terminated at 19 gesta-
tional weeks with cystic hygroma, joint contractures, facioc-
ranial dysmorphism, hypertelorism, a depressed nasal bridge,
micrognathia, low-set ears, contractures, pterygia, rocker-
bottom feet, lung hypoplasia, hydrothorax, pericardial effu-
sion, and shortened ribs. The third male fetus was terminated
at 12 gestational weeks with cystic hygroma, decreased
movements, joint contractures, contractures, and pterygia. The
fourth male fetus was terminated at 13 gestational weeks with
IUGR, cystic hygroma, decreased movements, joint contrac-
tures, micrognathia, low-set ears, contractures, and pterygia.
The fifth male fetus was terminated at 19 gestational weeks
with IUGR, edema, cystic hygroma, joint contractures,
faciocranial dysmorphism, down-slanting palpebral fissures,
hypertelorism, a depressed nasal bridge, micrognathia, low-set
ears, contractures, and pterygia.CHRNGHomozygous and compound heterozygous mutations in
CHRNG have been reported to cause autosomal-recessive
Escobar syndrome (OMIM 265000) and LMPS [18,24].
Morgan et al [18] reported two sibs of different sex in
a consanguineous Arab family with LMPS and a homozygous
missense mutation of c.320 T/G in CHRNG that predicts
p.Val107Gly. The sister died at age 3 months because of
congenital heart disease, and the brother died at age 3 days
because of lung hypoplasia. Morgan et al [18] also reported
a male fetus in a consanguineous Turkish family with LMPS
and a homozygous frameshift mutation of c.753_754delCT in
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hydrops at 13 weeks of gestation and was terminated at 15 weeks
of gestation with down-slanting palpebral fissures, low-set ears,
micrognathia, deviation of the wrists, bilateral talipes, unfixed
colon, mild thoracic scoliosis, and reduced muscle bulk. Morgan
et al [18] additionally reported a 37-gestational-week female
fetus in a non-consanguineous family with hydrops, bilateral
pleural effusions, skin edema, hydronephrotic right kidney,
pterygia, rocker-bottom feet, lung hypoplasia, neonatal death,
and a homozygous frameshift mutation of c.459dupA in
CHRNG that predicts p.Val154SerfsX24.RAPSNThe RAPSN gene encodes a postsynaptic protein that
functions as a link between AchR and the agrin-binding dys-
trophin-associated glycoprotein complex to stabilize AchR
at the NMJ [25]. Homozygous or compound heterozygous
mutations in RAPSN can cause autosomal recessive FADS and
congenital myasthenic syndrome associated with AchR defi-
ciency (OMIM 608931). Michalk et al [12] reported two sibs
of different sex with FADS in a non-consanguineous Pakistani
family. The sibs were born at term with severe respiratory
problems, inborn contractures, down-slanting palpebral
fissures, mild hypertelorism, a wide nasal bridge, low-set ears,
micrognathia, a small mouth, tented lips, hypotonia, but no
pterygia. The brother had cryptorchidism and died of respira-
tory problems at age 10 months, and the sister had cleft palate
but was alive at age 10 months. Both sibs had compound
heterozygous mutations of c.416 T/C/ c.566C/T in RAPSN
that predict F139S/A189 V. Vogt et al [5] reported three sibs
(two twin males and one female) with FADS and a homozy-
gous mutation of c.1177_1178delAA in RAPSN that predicts
a frameshift after residue 392 of rapsyn resulting in 82
C-terminal missense amino acids. The monozygotic twin
males were found to have FADS, micrognathia, fixed position
of the extremities, a small thorax, no respiratory movements,
and mild hydrops at 19 weeks of gestation. The pregnancy was
terminated at 23 weeks of gestation, and the fetuses manifested
a flat facial profile, hypertelorism, moderate micrognathia,
a short broad neck, mild hydrops, hydrothorax, subcutaneous
edema, hypoplastic lungs, abnormal posture, hyperextension
of the wrists, flexion of the fingers, fixed ankles, hyper-
extended toes, but no pterygia. The female singleton was
found to have FADS at 19 weeks of gestation, and the preg-
nancy was terminated at 23 weeks of gestation. The fetus
postnatally manifested micrognathia, low-set ears, a short
nose, a short philtrum, thin lips, a short broad neck, subcuta-
neous edema of the head, neck and shoulders, abnormally fixed
elbows, hyperextended wrists, and overlapping fingers, but no
pterygia.DOC7The DOC7 gene encodes a muscle protein that is essential
for synaptogenesis through its interaction with MuSK (OMIM
601296), a skeletal muscle receptor tyrosine kinase thatorchestrates postsynaptic differentiation including the clus-
tering of receptors for the neurotransmitter acetylcholine
[26]. Homozygous or compound heterozygous mutations in
DOC7 can cause autosomal recessive FADS and familial limb-
girdle myasthenia (OMIM 254300). Vogt et al [5] identified
a homozygous DOC7 splice site mutation of IVS3þ1 G > Tor
c.331 þ 1 G > T in a consanguineous Bengali family with
three fetuses affected with FADS but no pterygia. The first
fetus was stillborn at 32 weeks of gestation with a neuromus-
cular disorder. The second fetus was miscarried at 22 weeks of
gestation with down-slanting palpebral fissures, a small jaw,
a short neck, extended extremities, overlapping fingers, bilat-
eral talipes, rocker-bottom feet, bilateral hydrothorax, severe
generalized edema, and reduced muscle bulk. The third fetus
was found to have no fetal movements on prenatal ultrasound
at 24 weeks of gestation.CNTN1The CNTN1 gene encodes a neural adhesion and NMJ
protein that is restricted to the NMJ and function for NMJ
adhesion [27]. Homozygous mutations in CNTN1 can cause
severe fetal akinesia and ComptoneNorth congenital myop-
athy (OMIM 612540). Compton et al [27] identified a homo-
zygous 1-bp duplication (c.871dupT) in exon 8 of CNTN1 that
results in a frameshift and premature truncation (S291fsX296)
within the third Ig domain and predicts a nonsense-mediated
mRNA decay.SYNE1The SYNE1 gene encodes a synaptic nuclear envelope
protein 1 or nesprin 1. Nesprin 1 anchors specialized myo-
nuclei underneath NMJ, binds lamin A and emerin, and
interacts with the cytoplasmic domain of MuSK [28e31].
Mutations in SYNE1 can cause autosomal-recessive spino-
cerebellar ataxia 8 (OMIM 610743), autosomal-dominant
EmeryeDreifuss muscular dystrophy 4 (OMIM 612998),
and autosomal-recessive myogenic arthrogryposis multiplex
congenita [32]. Attali et al [32] identified homozygosity for an
acceptor site mutation 2-bp 50 to exon 137 in SYNE1 (IVS136-
2 A > G) that predicts retention of intron 136 in mRNA and
generates a premature stop codon and loss of the C-terminal
transmembrane KASH domain in a two-generation consan-
guineous family with arthrogryposis, decreased fetal move-
ments, hypotonia, delayed motor milestones, and progressive
motor decline after the first decade. In that family, a brother of
affected children married his first cousin who had two preg-
nancies that manifested bilateral clubfeet and decreased fetal
movements at 28 and 16 weeks of gestation in the first and
second fetuses, respectively.
Prenatal diagnosis of FADS/MPS by ultrasound and
magnetic resonance imaging
Prenatal diagnosis of reduced or absent fetal movements
in association with abnormal fetal posture should include
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ryposis, FADS, fetal constraint, body stalk anomaly, caudal
regression sequence, fetal hypoxia/severe hypotonia, amniotic
bands, fetal neck masses, joint dislocations, vertebral
segmentation abnormalities, iniencephaly, and MPS [33].
Fetal akinesia/arthrogryposis can result from primary defects
of brain, spinal cord, peripheral nerves, NMJ, skeletal
musculature and connective tissues, vascular compromise,
restricted intrauterine space, teratogenic exposures, ischemia,
maternal illness, and circulating maternal antibodies to
neurotransmitters, myelin, and muscle proteins [34,35]. Fetal
akinesia can be detected by prenatal ultrasound as early as 12
weeks of gestation [36]. Prenatal ultrasound findings of fetal
akinesia/arthrogryposis include lack of extremity motions,
persistent abnormal posture of the limbs, lack of facial
movements, polyhydramnios due to decreased fetal swallow-
ing, pulmonary hypoplasia, a short umbilical cord due to
decreased fetal movements, IUGR, increased nuchal trans-
lucency, nuchal edema or cystic hygroma in the first trimester,
and hydrops fetalis [36e65]. Fetal magnetic resonance
imaging can be a useful adjunct to prenatal ultrasound in
evaluating central nervous system findings [62,65]. The
abnormal neurological magnetic resonance imaging findings
include agenesis of the corpus callosum, lissencephaly,
hydrocephalus, and spinal cord abnormalities [37]. Prenatal
ultrasound findings of Escobar MPS include small stature,
multiple pterygia of neck, axillae, elbows and knees, micro-
gnathia, digital hypoplasia, camptodactyly, syndactyly, and
scoliosis [66]. Prenatal ultrasound findings with LMPS
include IUGR, flexion contractures of the limbs, multiple
extensive pterygia, cystic hygroma, hydrops, and hypoplastic
lungs [67e77].
In summary, this article provides a comprehensive review
of prenatal diagnosis and genetic analysis of FADS/MPS
associated with NMJ disorders. Prenatal diagnosis of fetal
akinesia along with cystic hygroma, increased nuchal trans-
lucency, nuchal edema, hydrops fetalis, arthrogryposis, pter-
ygia, and other structural abnormalities should include
a differential diagnosis of NMJ disorders. Genetic analysis of
mutations in the genes associated with NMJ may unveil the
pathogenetic cause of FADS/MPS, and the information
acquired is helpful for genetic counseling and clinical
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